Literature DB >> 10443916

The effect of cyst(e)ine on the auto-oxidation of homocysteine.

N Hogg1.   

Abstract

This study examines the effect of cysteine on the auto-oxidation of homocysteine, a process that has been implicated in the pathologic mechanism of hyperhomocystinemia with respect to arteriosclerosis and vascular disease. It is shown that homocysteine autoxidizes at a much slower rate than cysteine, but that low concentrations of cysteine or cystine dramatically accelerate homocysteine oxidation and increase the rate of homocysteine-dependent oxygen consumption. It is proposed that the major role of homocysteine is to reduce cystine to cysteine, and that cysteine autoxidation is the mechanism by which thiol-dependent oxidative stress occurs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443916     DOI: 10.1016/s0891-5849(99)00029-5

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  25 in total

1.  Hyperhomocysteinemia abrogates fasting-induced cardioprotection against ischemia/reperfusion by limiting bioavailability of hydrogen sulfide anions.

Authors:  Shintaro Nakano; Isao Ishii; Ken Shinmura; Kayoko Tamaki; Takako Hishiki; Noriyuki Akahoshi; Tomoaki Ida; Tsuyoshi Nakanishi; Shotaro Kamata; Yoshito Kumagai; Takaaki Akaike; Keiichi Fukuda; Motoaki Sano; Makoto Suematsu
Journal:  J Mol Med (Berl)       Date:  2015-03-06       Impact factor: 4.599

Review 2.  The thiol pool in human plasma: the central contribution of albumin to redox processes.

Authors:  Lucía Turell; Rafael Radi; Beatriz Alvarez
Journal:  Free Radic Biol Med       Date:  2013-06-07       Impact factor: 7.376

3.  Attenuation of ecstasy-induced neurotoxicity by N-acetylcysteine.

Authors:  Sara Soleimani Asl; Bita Saifi; Abolhasan Sakhaie; Somayeh Zargooshnia; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2014-08-06       Impact factor: 3.584

4.  Pretreatment with vitamins E and C prevent the impairment of memory caused by homocysteine administration in rats.

Authors:  Eleonora A Reis; Alexandra I Zugno; Renata Franzon; Bárbara Tagliari; Cristiane Matté; Marcelo L Lammers; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

5.  Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.

Authors:  Andrew D Bolton; Marnie A Phillips; Martha Constantine-Paton
Journal:  J Neurophysiol       Date:  2013-07-17       Impact factor: 2.714

6.  The activity of erythrocyte and brain Na+/K+ and Mg2+-ATPases in rats subjected to acute homocysteine and homocysteine thiolactone administration.

Authors:  Aleksandra Rasić-Marković; Olivera Stanojlović; Dragan Hrncić; Danijela Krstić; Mirjana Colović; Veselinka Susić; Tatjana Radosavljević; Dragan Djuric
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

7.  Reduction of Na(+),K(+)-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia.

Authors:  Emílio L Streck; Cristiane Matte; Paula S Vieira; Fernanda Rombaldi; Clóvis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

8.  Inhibition of Na(+),K(+)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment.

Authors:  Angela T S Wyse; Alexandra I Zugno; Emilio L Streck; Cristiane Matté; Thiago Calcagnotto; Clovis M D Wannmacher; Moacir Wajner
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

9.  Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives.

Authors:  R Pandey; S Gupta; H Lal; H C Mehta; S K Aggarwal
Journal:  Indian J Clin Biochem       Date:  2000-08

10.  Inhibition of Na+, K+-ATPase activity by the metabolites accumulating in homocystinuria.

Authors:  Emilio L Streck; Alexandra I Zugno; Barbara Tagliari; Clovis Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2002-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.